194 related articles for article (PubMed ID: 12477854)
1. Promoter sequences of varicella-zoster virus glycoprotein I targeted by cellular transactivating factors Sp1 and USF determine virulence in skin and T cells in SCIDhu mice in vivo.
Ito H; Sommer MH; Zerboni L; He H; Boucaud D; Hay J; Ruyechan W; Arvin AM
J Virol; 2003 Jan; 77(1):489-98. PubMed ID: 12477854
[TBL] [Abstract][Full Text] [Related]
2. The immediate-early 63 protein of Varicella-Zoster virus: analysis of functional domains required for replication in vitro and for T-cell and skin tropism in the SCIDhu model in vivo.
Baiker A; Bagowski C; Ito H; Sommer M; Zerboni L; Fabel K; Hay J; Ruyechan W; Arvin AM
J Virol; 2004 Feb; 78(3):1181-94. PubMed ID: 14722273
[TBL] [Abstract][Full Text] [Related]
3. The ubiquitous cellular transcriptional factor USF targets the varicella-zoster virus open reading frame 10 promoter and determines virulence in human skin xenografts in SCIDhu mice in vivo.
Che X; Berarducci B; Sommer M; Ruyechan WT; Arvin AM
J Virol; 2007 Apr; 81(7):3229-39. PubMed ID: 17251302
[TBL] [Abstract][Full Text] [Related]
4. Cellular and viral factors regulate the varicella-zoster virus gE promoter during viral replication.
Berarducci B; Sommer M; Zerboni L; Rajamani J; Arvin AM
J Virol; 2007 Oct; 81(19):10258-67. PubMed ID: 17634217
[TBL] [Abstract][Full Text] [Related]
5. Aberrant infection and persistence of varicella-zoster virus in human dorsal root ganglia in vivo in the absence of glycoprotein I.
Zerboni L; Reichelt M; Jones CD; Zehnder JL; Ito H; Arvin AM
Proc Natl Acad Sci U S A; 2007 Aug; 104(35):14086-91. PubMed ID: 17709745
[TBL] [Abstract][Full Text] [Related]
6. Glycoprotein I of varicella-zoster virus is required for viral replication in skin and T cells.
Moffat J; Ito H; Sommer M; Taylor S; Arvin AM
J Virol; 2002 Aug; 76(16):8468-71. PubMed ID: 12134050
[TBL] [Abstract][Full Text] [Related]
7. Regulation of the ORF61 promoter and ORF61 functions in varicella-zoster virus replication and pathogenesis.
Wang L; Sommer M; Rajamani J; Arvin AM
J Virol; 2009 Aug; 83(15):7560-72. PubMed ID: 19457996
[TBL] [Abstract][Full Text] [Related]
8. Functions of the C-terminal domain of varicella-zoster virus glycoprotein E in viral replication in vitro and skin and T-cell tropism in vivo.
Moffat J; Mo C; Cheng JJ; Sommer M; Zerboni L; Stamatis S; Arvin AM
J Virol; 2004 Nov; 78(22):12406-15. PubMed ID: 15507627
[TBL] [Abstract][Full Text] [Related]
9. Mutational analysis of open reading frames 62 and 71, encoding the varicella-zoster virus immediate-early transactivating protein, IE62, and effects on replication in vitro and in skin xenografts in the SCID-hu mouse in vivo.
Sato B; Ito H; Hinchliffe S; Sommer MH; Zerboni L; Arvin AM
J Virol; 2003 May; 77(10):5607-20. PubMed ID: 12719553
[TBL] [Abstract][Full Text] [Related]
10. Varicella-zoster virus open reading frame 10 is a virulence determinant in skin cells but not in T cells in vivo.
Che X; Zerboni L; Sommer MH; Arvin AM
J Virol; 2006 Apr; 80(7):3238-48. PubMed ID: 16537591
[TBL] [Abstract][Full Text] [Related]
11. The DNA element controlling expression of the varicella-zoster virus open reading frame 28 and 29 genes consists of two divergent unidirectional promoters which have a common USF site.
Yang M; Hay J; Ruyechan WT
J Virol; 2004 Oct; 78(20):10939-52. PubMed ID: 15452214
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the functions of glycoproteins E and I and their promoters during VZV replication in vitro and in skin and T-cell xenografts in the SCID mouse model of VZV pathogenesis.
Arvin AM; Oliver S; Reichelt M; Moffat JF; Sommer M; Zerboni L; Berarducci B
Curr Top Microbiol Immunol; 2010; 342():129-46. PubMed ID: 20186616
[TBL] [Abstract][Full Text] [Related]
13. Cellular factors and IE62 activation of VZV promoters.
Ruyechan WT; Peng H; Yang M; Hay J
J Med Virol; 2003; 70 Suppl 1():S90-4. PubMed ID: 12627495
[TBL] [Abstract][Full Text] [Related]
14. An Sp1/Sp3 site in the downstream region of varicella-zoster virus (VZV) oriS influences origin-dependent DNA replication and flanking gene transcription and is important for VZV replication in vitro and in human skin.
Khalil MI; Robinson M; Sommer M; Arvin A; Hay J; Ruyechan WT
J Virol; 2012 Dec; 86(23):13070-80. PubMed ID: 22933283
[TBL] [Abstract][Full Text] [Related]
15. Differential effects of Sp cellular transcription factors on viral promoter activation by varicella-zoster virus (VZV) IE62 protein.
Khalil MI; Ruyechan WT; Hay J; Arvin A
Virology; 2015 Nov; 485():47-57. PubMed ID: 26207799
[TBL] [Abstract][Full Text] [Related]
16. Transcription factor USF, expressed during the entire phase of varicella-zoster virus infection, interacts physically with the major viral transactivator IE62 and plays a significant role in virus replication.
Rahaus M; Desloges N; Yang M; Ruyechan WT; Wolff MH
J Gen Virol; 2003 Nov; 84(Pt 11):2957-2967. PubMed ID: 14573800
[TBL] [Abstract][Full Text] [Related]
17. Deletion of the first cysteine-rich region of the varicella-zoster virus glycoprotein E ectodomain abolishes the gE and gI interaction and differentially affects cell-cell spread and viral entry.
Berarducci B; Rajamani J; Reichelt M; Sommer M; Zerboni L; Arvin AM
J Virol; 2009 Jan; 83(1):228-40. PubMed ID: 18945783
[TBL] [Abstract][Full Text] [Related]
18. Attenuation of the vaccine Oka strain of varicella-zoster virus and role of glycoprotein C in alphaherpesvirus virulence demonstrated in the SCID-hu mouse.
Moffat JF; Zerboni L; Kinchington PR; Grose C; Kaneshima H; Arvin AM
J Virol; 1998 Feb; 72(2):965-74. PubMed ID: 9444989
[TBL] [Abstract][Full Text] [Related]
19. The ORF47 and ORF66 putative protein kinases of varicella-zoster virus determine tropism for human T cells and skin in the SCID-hu mouse.
Moffat JF; Zerboni L; Sommer MH; Heineman TC; Cohen JI; Kaneshima H; Arvin AM
Proc Natl Acad Sci U S A; 1998 Sep; 95(20):11969-74. PubMed ID: 9751774
[TBL] [Abstract][Full Text] [Related]
20. Varicella-zoster virus glycoprotein E is a critical determinant of virulence in the SCID mouse-human model of neuropathogenesis.
Zerboni L; Berarducci B; Rajamani J; Jones CD; Zehnder JL; Arvin A
J Virol; 2011 Jan; 85(1):98-111. PubMed ID: 20962081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
